For the quarter ending 2026-03-29, JNJ made $24,062M in revenue. $5,235M in net income. Net profit margin of 21.76%.
| Income Statement | 2026-03-29 | 2025-12-28 | 2025-09-28 | 2025-06-29 |
|---|---|---|---|---|
| Sales to customers (note 9) | 24,062 | 24,564 | 23,993 | 23,743 |
| Cost of products sold | 8,106 | 7,968 | 7,303 | 7,628 |
| Gross profit | 15,956 | 16,596 | 16,690 | 16,115 |
| Selling, marketing and administrative expenses | 6,034 | 6,753 | 5,922 | 5,889 |
| Research and development expense | 3,527 | 4,252 | 3,672 | 3,516 |
| In-process research and development impairments | 36 | 81 | - | 0 |
| Interest income | 229 | 237 | 227 | 260 |
| Interest expense, net of portion capitalized | 272 | 214 | 245 | 308 |
| Other (income) expense, net | -294 | -483 | 478 | -107 |
| Restructuring (note 12) | 32 | 84 | 63 | 64 |
| Earnings before provision for taxes on income | 5,990 | 4,966 | 7,493 | 6,491 |
| Provision for taxes on income (note5) | 755 | -150 | 2,341 | 954 |
| Net earnings from continuing operations | - | 5,116* | - | - |
| Net earnings from discontinued operations | - | 0* | - | - |
| Net earnings | 5,235 | 5,116 | 5,152 | 5,537 |
| Basic EPS | 2.17 | 2.125 | 2.14 | 2.3 |
| Diluted EPS | 2.14 | 2.091 | 2.12 | 2.29 |
| Basic Average Shares | 2,408,700,000 | 2,407,800,000 | 2,408,300,000 | 2,406,300,000 |
| Diluted Average Shares | 2,445,200,000 | 2,446,100,000 | 2,428,600,000 | 2,419,100,000 |
JOHNSON & JOHNSON (JNJ)
JOHNSON & JOHNSON (JNJ)